How has COVID-19 altered your recommendations for invasive mediastinal staging for NSCLC?
Should staging and treatment decisions be made based on imaging alone?
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · City of Hope
Answered on
I just had this discussion with our chief of interventional pulmonolgy at MD Anderson. Some of his faculty are being asked to staff our COVID-19 patient floor. In addition, bronchoscopy procedures should be considered high-risk procedures, and are required to have at least 45 minutes in between proc...
Join for free or sign in to see the full answer
Mednet Member
Medical Oncology · Yale Cancer Center
Answered on
It certainly has pushed me more to using EBUS than mediastinoscopy and having to give patients the benefit of the doubt even when the EBUS retrieves only a small sample.
Join for free or sign in to see the full answer